Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity
Rebecca Elstrom(Acentech (United States)), Usama Gergis(Thomas Jefferson University Hospital), John P. Leonard(New York University), Peter Martin(Northwestern University), Jia Ruan(Cornell University), Tomer M. Mark(University of Colorado Hospital), Tsiporah B. Shore(Cornell University), Morton Coleman(Cornell University), Richard R. Furman(Cornell University), Roger Pearse(Cornell University), Sandra Hurtado Rúa(Cleveland State University)
Cited by 42
Related Papers
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k